Published in N Engl J Med on November 10, 1994
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
Thyroid status, cardiovascular risk, and mortality in older adults. JAMA (2006) 3.50
Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ (2011) 2.97
Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid (2012) 2.78
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ (2012) 2.65
Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation (2011) 2.36
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
Thyroid status and 6-year mortality in elderly people living in a mildly iodine-deficient area: the aging in the Chianti Area Study. J Am Geriatr Soc (2013) 2.10
Using body mass index to predict optimal thyroid dosing after thyroidectomy. J Am Coll Surg (2013) 2.10
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ (2007) 2.07
Management of the unexpected result: compensated hypothyroidism. Postgrad Med J (1998) 2.02
2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J (2013) 1.87
Status of the epidemiology of atrial fibrillation. Med Clin North Am (2008) 1.80
Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation (2012) 1.79
Atrial fibrillation and the pituitary-thyroid axis: a re-evaluation. Heart (1997) 1.51
Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch Intern Med (2008) 1.40
Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin (2009) 1.38
Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis. Nat Med (2009) 1.36
Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol (2010) 1.28
Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. J Am Coll Cardiol (2009) 1.26
Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism. J Clin Endocrinol Metab (2012) 1.20
Thyroid disease and the heart. Heart (2000) 1.18
Management of subclinical hypothyroidism: the thyroidologists' view. Eur Thyroid J (2012) 1.09
High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab (2009) 1.08
Controversial aspects of thyroid disease. BMJ (1999) 1.07
Arrhythmia and thyroid dysfunction. Herz (2014) 1.07
Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Arch Med Sci (2013) 1.05
The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Res (2009) 1.03
Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther (2011) 1.02
Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature. World J Surg (2008) 1.02
Subclinical hypothyroidism in children: natural history and when to treat. J Clin Res Pediatr Endocrinol (2012) 0.98
Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart (1996) 0.97
Subclinical thyroid dysfunction and cognitive decline in old age. PLoS One (2013) 0.93
The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence. Heart Fail Rev (2008) 0.93
Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012. J Clin Endocrinol Metab (2015) 0.92
The role of thyroid hormones as inductors of oxidative stress and neurodegeneration. Oxid Med Cell Longev (2013) 0.91
Hypothyroidism, thyroxine treatment, and the heart. Heart (1997) 0.90
Subclinical hyperthyroidism: to treat or not to treat? Postgrad Med J (2004) 0.90
Nonthyroidal illness and the cardiorenal syndrome. Nat Rev Nephrol (2013) 0.89
New questions regarding bioequivalence of levothyroxine preparations: a clinician's response. AAPS J (2005) 0.89
Atrial fibrillation pearls and perils of management. West J Med (1996) 0.89
Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function. PLoS One (2012) 0.89
The prevalence of thyroid dysfunction in elderly cardiology patients with mild excessive iodine intake in the urban area of São Paulo. Clinics (Sao Paulo) (2009) 0.89
Association of inflammation with atrial fibrillation in hyperthyroidism. J Geriatr Cardiol (2012) 0.88
Guidance in Subclinical Hyperthyroidism and Subclinical Hypothyroidism: Are We Making Progress? Eur Thyroid J (2015) 0.87
Predictors of thyroid hormone initiation in older adults: results from the cardiovascular health study. J Gerontol A Biol Sci Med Sci (2011) 0.87
Approach to and treatment of thyroid disorders in the elderly. Med Clin North Am (2012) 0.86
Hyperthyroidism. Med Sci Monit (2011) 0.86
Thyroid function and left ventricular structure and function in the Framingham Heart Study. Thyroid (2010) 0.85
Hyperthyroidism. Lancet (2016) 0.85
Thyroid dysfunction in the elderly. Nat Rev Endocrinol (2013) 0.85
Clinical review: The thyroid in mind: cognitive function and low thyrotropin in older people. J Clin Endocrinol Metab (2012) 0.85
Atrial fibrillation in a tertiary care institute - a prospective study. Indian Heart J (2012) 0.84
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J (2015) 0.84
Subclinical hyperthyroidism--just a low serum thyrotropin concentration, or something more? N Engl J Med (1994) 0.84
Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study). Am Heart J (2013) 0.83
Evidence-based management of toxic multinodular goiter (Plummer's Disease). World J Surg (2008) 0.83
Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF. Neurology (2015) 0.82
Central hypothyroidism. Indian J Endocrinol Metab (2011) 0.82
Thyroid and aging or the aging thyroid? An evidence-based analysis of the literature. J Thyroid Res (2013) 0.82
Genetic associations with neonatal thyroid-stimulating hormone levels. Pediatr Res (2013) 0.82
Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study. J Clin Endocrinol Metab (2016) 0.81
Thyroid cancer: possible role of telemedicine. Acta Otorhinolaryngol Ital (2008) 0.81
Thyroid function tests in patients taking thyroid medication in Germany: Results from the population-based Study of Health in Pomerania (SHIP). BMC Res Notes (2010) 0.81
Atrial fibrillation and hyperthyroidism. Indian Pacing Electrophysiol J (2005) 0.81
Thyrotoxic atrial fibrillation. MedGenMed (2005) 0.81
Prediction of atrial fibrillation development and progression: Current perspectives. World J Cardiol (2016) 0.80
Validation of a decision rule for selective TSH screening in atrial fibrillation. West J Emerg Med (2015) 0.79
Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study. Clin Endocrinol (Oxf) (2014) 0.79
Current concepts of thyroid function and laboratory evaluation. Indian J Clin Biochem (1997) 0.79
Mortality and coronary heart disease in euthyroid patients. Am J Med (2012) 0.79
Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging. Thyroid (2015) 0.79
Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma. Eur Arch Otorhinolaryngol (2015) 0.78
Geriatric thyroidology: An update. Indian J Endocrinol Metab (2012) 0.78
P wave duration and dispersion in patients with hyperthyroidism and the short-term effects of antithyroid treatment. Indian Pacing Electrophysiol J (2009) 0.78
Thyroid Hormone Replacement in Patients Following Thyroidectomy for Thyroid Cancer. Rambam Maimonides Med J (2016) 0.77
The Propensity for Inducing Atrial Fibrillation: A Comparative Study on Old versus Young Rabbits. J Aging Res (2014) 0.77
Completion of guideline-recommended initial evaluation of atrial fibrillation. Clin Cardiol (2012) 0.77
TSH Measurement and Its Implications for Personalised Clinical Decision-Making. J Thyroid Res (2012) 0.76
Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study. Evid Based Complement Alternat Med (2015) 0.76
Is annual surveillance of all treated hypothyroid patients necessary? BMC Endocr Disord (2007) 0.76
Prevalence of unknown thyroid disorders in a Sardinian cohort. Eur J Endocrinol (2014) 0.76
Prognosis of papillary thyroid carcinoma in elderly patients after thyroid resection: A retrospective cohort analysis. Medicine (Baltimore) (2016) 0.75
Management of subclinical hyperthyroidism. Int J Endocrinol Metab (2012) 0.75
Hyperthyroidism (primary). BMJ Clin Evid (2008) 0.75
Thyroid function tests and hypothyroidism. Reducing concentrations further would be harmful. BMJ (2003) 0.75
Masked hyperthyroidism in a haemodialysis patient successfully treated by potassium iodide. Clin Kidney J (2012) 0.75
Hyperthyroidism (primary). BMJ Clin Evid (2010) 0.75
Hyperthyroidism and jaundice. Indian J Nucl Med (2010) 0.75
Hypothyroidism (primary). BMJ Clin Evid (2010) 0.75
Physiopathological aspects of the subclinical alterations of thyroid function associated with acute coronary syndromes. J Med Life (2013) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
STATISTICAL METHODS AND CONTROL IN BACTERIOLOGY. Bacteriol Rev (1943) 6.32
The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med (1999) 6.22
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science (1991) 5.99
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med (2001) 5.68
BIOLOGICAL DETERMINATION OF VITAMIN B1 (THIAMIN) IN RHIZOBIUM TRIFOLII. Science (1938) 5.59
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Mechanism of Biological Nitrogen Fixation: VI. Inhibition of Azotobacter by Hydrogen. Proc Natl Acad Sci U S A (1941) 5.23
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA (1993) 5.21
Formation of the nitrogen-fixing enzyme system in Azotobacter vinelandii. Can J Microbiol (1968) 5.05
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52
Mechanism of biological nitrogen fixation: Molecular H(2) and the pN(2) function of azotobacter. Biochem J (1941) 4.45
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Fragile X genotype characterized by an unstable region of DNA. Science (1991) 4.33
Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med (1993) 4.30
A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med (1984) 4.29
Inverse association of dietary fat with development of ischemic stroke in men. JAMA (1998) 4.20
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Long-term follow-up results of a randomized drug abuse prevention trial in a white middle-class population. JAMA (1995) 3.98
Competency development in public health leadership. Am J Public Health (2000) 3.84
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr (2001) 3.80
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Variability of body weight and health outcomes in the Framingham population. N Engl J Med (1991) 3.61
Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J (2000) 3.61
Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes (2000) 3.60
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
The Relationship Between Photosynthesis and Nitrogen Fixation. Proc Natl Acad Sci U S A (1952) 3.47
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
NITROGEN FIXATION BY PHOTOSYNTHETIC BACTERIA. J Bacteriol (1949) 3.33
Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology (2010) 3.27
INFLUENCE OF POTASSIUM NITRATE ON NODULE FORMATION AND NITROGEN FIXATION BY CLOVER. Plant Physiol (1932) 3.23
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord (2003) 3.23
Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 3.09
Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr (1994) 3.08
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
ENZYME LOCALIZATION IN Azotobacter Vinelandii. Proc Natl Acad Sci U S A (1955) 2.97
Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology (2004) 2.97
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Improved cloning vectors and transformation procedure for Lactococcus lactis. J Appl Bacteriol (1993) 2.91
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91
The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg (1993) 2.91
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81